Document Detail


Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure.
MedLine Citation:
PMID:  21036777     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Traditionally, VO(2peak) has been used to determine prognosis in heart failure; however, this measure has limitations. Hence, other exercise and gas exchange parameters measured submaximally, e.g. breathing efficiency (V(E)/VCO(2)), end-tidal CO(2) (P(ET)CO(2)), oxygen uptake efficiency slope (OUES), and circulatory power [ systolic blood pressure (SBP)], have been investigated. The aim of this study was to investigate the prognostic relevance of submaximal exercise gas exchange in heart failure patients. Method and results One hundred and thirty-two consecutive heart failure patients (mean age 56 ± 12 years, ejection fraction 29 ± 11%) performed peak treadmill testing. Gas exchange and haemodynamic variables were measured continuously. Gas exchange data obtained from the first 2 min of exercise and at a respiratory exchange ratio (RER) of 0.9 were the measurements of interest. Over a median follow-up period of 62.4 (range 0-114) months, there were 44 endpoints (death or transplant). Univariate analysis demonstrated submaximal predictors of survival, which included V(E)/VCO(2) slope and ratio, P(ET)CO(2), OUES, and circulatory power (P ≤ 0.01). When these and additional submaximal variables were included together in the multivariable analysis, the strongest submaximal exercise predictive model (C-statistic 0.75) comprised data from the first stage of exercise (V(E) and circulatory power) and at an RER of 0.9 (V(E)/VCO(2) ratio). The inclusion of VO(2 peak) and demographic data, with submaximal data (V(E)/VCO(2) ratio at an RER = 0.9), increased the predictiveness of the model (C-statistic 0.78).
CONCLUSION: Submaximal exercise measures provide useful prognostic information for predicting survival in heart failure. This form of testing is logistically easier, cheaper, and safer for patients compared with maximal exercise.
Authors:
Paul R Woods; Kent R Bailey; Christina M Wood; Bruce D Johnson
Related Documents :
19155077 - Heart rate dynamic during an exercise test in heart failure patients with different sen...
1971597 - A patient-powered treadmill--a simple alternative means of assessing heart failure and ...
10362197 - Relationship between exertional symptoms and functional capacity in patients with heart...
12172067 - Effects of an enhanced heart rate reserve on aerobic performance in patients with a hea...
23551197 - An exploratory microdialysis study investigating the effect of repeated application of ...
2432577 - Measurement of right ventricular blood temperature during exercise as a means of rate c...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-10-29
Journal Detail:
Title:  European journal of heart failure     Volume:  13     ISSN:  1879-0844     ISO Abbreviation:  Eur. J. Heart Fail.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-21     Completed Date:  2011-06-23     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  100887595     Medline TA:  Eur J Heart Fail     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  303-10     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Disease, Mayo Clinic, Joseph 4-225D, Rochester, MN 55902, USA. woods.paul@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Exercise Test / methods*
Female
Follow-Up Studies
Heart Failure / diagnosis*,  mortality
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Proportional Hazards Models
Pulmonary Gas Exchange*
Grant Support
ID/Acronym/Agency:
HL71478/HL/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute S...
Next Document:  Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure.